ZANARDINI, ROBERTA
 Distribuzione geografica
Continente #
NA - Nord America 4.466
EU - Europa 1.254
AS - Asia 460
Continente sconosciuto - Info sul continente non disponibili 11
AF - Africa 5
OC - Oceania 2
SA - Sud America 2
Totale 6.200
Nazione #
US - Stati Uniti d'America 4.398
DE - Germania 513
CN - Cina 406
UA - Ucraina 270
SE - Svezia 121
RU - Federazione Russa 98
GB - Regno Unito 93
CA - Canada 68
FI - Finlandia 49
IE - Irlanda 44
SG - Singapore 34
FR - Francia 27
IT - Italia 23
EU - Europa 11
PL - Polonia 8
IL - Israele 4
TR - Turchia 4
BE - Belgio 3
IN - India 3
AE - Emirati Arabi Uniti 2
CM - Camerun 2
AU - Australia 1
BR - Brasile 1
BY - Bielorussia 1
DZ - Algeria 1
EC - Ecuador 1
EG - Egitto 1
ES - Italia 1
GR - Grecia 1
HK - Hong Kong 1
HU - Ungheria 1
ID - Indonesia 1
IR - Iran 1
JO - Giordania 1
LY - Libia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
RO - Romania 1
TH - Thailandia 1
VN - Vietnam 1
Totale 6.200
Città #
Fairfield 940
Seattle 431
Ashburn 421
Woodbridge 414
Houston 386
Cambridge 376
Beijing 367
Wilmington 312
Chandler 247
Jacksonville 231
Ann Arbor 124
Ottawa 64
Dublin 44
Lawrence 42
Princeton 42
London 29
New York 28
Boardman 26
Helsinki 26
San Diego 26
Norwalk 14
Kunming 13
Prescot 12
Chiswick 10
Los Angeles 10
Kraków 7
Nanjing 6
Redwood City 6
Milan 5
St Louis 5
Chengdu 4
Dearborn 4
Hefei 4
Redmond 4
Brussels 3
Chicago 3
Falls Church 3
Islington 3
Mcallen 3
Montréal 3
Guangzhou 2
Hounslow 2
Jinan 2
Kocaeli 2
Miami Beach 2
Nanchang 2
New Bedfont 2
Secaucus 2
West Jordan 2
Abu Dhabi 1
Ampang 1
Andover 1
Ankara 1
Brisbane 1
Cairo 1
Cedar Knolls 1
Chesapeake 1
Chongqing 1
Dallas 1
Dubai 1
Focsani 1
Fuzhou 1
Genoa 1
Hamilton 1
Hanoi 1
Hanover 1
Jaraguari 1
Kazan 1
Kilburn 1
Madrid 1
Melzo 1
Minsk 1
Moscow 1
Nanning 1
Rander 1
Santo Domingo de los Colorados 1
Trapani 1
Washington 1
Wuhan 1
Yaroslavl 1
Yellowknife 1
Zhengzhou 1
Totale 4.749
Nome #
Immune and metabolic alterations in first episode psychosis (FEP) patients 322
Association between baseline serum vascular endothelial growth factor levels and response to electroconvulsive therapy. 254
BDNF serum levels, but not BDNF Val66Met genotype, are correlated with personality traits in healthy subjects 215
Serum leptin levels are higher in females affected by frontotemporal lobar degeneration than Alzheimer's disease 204
Promoter haplotypes of interleukin-10 gene and sporadic Alzheimer's disease 194
Effect of repetitive transcranial magnetic stimulation on serum brain derived neurotrophic factor in drug resistant depressed patients 187
Serum levels of brain-derived neurotrophic factor in drug-naive obsessive-compulsive patients: A case-control study 182
Serum and plasma BDNF levels in major depression: A replication study and meta-analyses 176
Serum Levels of Insulin-Like Growth Factor-1 and Obsessive-Compulsive Disorder: A Case-Control Study 173
BDNF Val66Met polymorphism and protein levels in Amniotic Fluid 168
Electroconvulsive Therapy (ECT) increases serum Brain Derived Neurotrophic Factor (BDNF) in drug resistant depressed patients 166
5-HTTLPR and BDNF Val66Met polymorphisms and response to rTMS treatment in drug resistant depression 164
Insulin-like growth factor binding protein 2 in bipolar disorder: An expression study in peripheral tissues 164
Alterations of Brain-Derived Neurotrophic Factor Serum Levels in Patients with Alcohol Dependence 162
Haptoglobin polymorphism and schizophrenia: Genetic variation on chromosome 16 159
Glucose metabolism alterations in patients with bipolar disorder 158
Vascular Endothelial Growth Factor (VEGF) serum concentration during electroconvulsive therapy (ECT) in treatment resistant depressed patients 155
Reduced peripheral brain-derived neurotrophic factor mRNA levels are normalized by antidepressant treatment 154
Association between promoter polymorphic haplotypes of interleukin-10 gene and schizophrenia 152
VEGF serum levels in depressed patients during SSRI antidepressant treatment 148
Cerebrospinal fluid markers for Alzheimer's disease in a cognitively healthy cohort of young and old adults. 148
A multi-element psychosocial intervention for early psychosis (GET UP PIANO TRIAL) conducted in a catchment area of 10 million inhabitants: study protocol for a pragmatic cluster randomized controlled trial 146
Serum brain-derived neurotrophic factor (BDNF) levels in attention deficit-hyperactivity disorder (ADHD) 141
Supporting evidence for using biomarkers in the diagnosis of MCI due to AD 141
The Heritability of Frontotemporal Lobar Degeneration: Validation of Pedigree Classification Criteria in a Northern Italy Cohort 140
Molecular Pathways Bridging Frontotemporal Lobar Degeneration and Psychiatric Disorders 138
The 196G/A (val66met) polymorphism of the BDNF gene is significantly associated with binge eating behavior in women with bulimia nervosa or binge eating disorder. 136
Altered Expression of circulating Cdc42 in frontotemporal lobar degeneration 134
Serum Brain-Derived Neurotrophic Factor Levels in Different Neurological Diseases 132
Association between -G308A tumor necrosis factor alpha gene polymorphism and schizophrenia 131
Influence of clotting duration on brain-derived neurotrophic factor (BDNF) dosage in serum. 130
Serum C-peptide, visfatin, resistin, and ghrelin are altered in sporadic and grn-associated frontotemporal lobar degeneration 125
Diagnostic accuracy of markers for prodromal Alzheimer's disease in independent clinical series 124
A case of non-beta-globin gene linked beta thalassaemia in a Dutch family with two additional alpha-gene defects: the common -alpha3.7 deletion and the rare IVS1-116 (A-->G) acceptor splice site mutation. 123
alpha-thalassaemia as a result of a novel splice donor site mutation of the alpha1-globin gene. 115
MCP-1 gene (SCYA2) and schizophrenia: a case-control association study. 114
The new Alzheimer's criteria in a naturalistic series of patients with mild cognitive impairment 114
Correlations between immune and metabolic serum markers and schizophrenia/bipolar disorder polygenic risk score in first-episode psychosis 102
Association between IL-1 beta-511C/T and IL-1RA (86bp)n repeats polymorphisms and schizophrenia 85
Molecular mechanisms in cognitive frailty: potential therapeutic targets for oxygen-ozone treatment 78
Childhood trauma and glucose metabolism in patients with first-episode psychosis 71
MiRNA Profiling in Plasma Neural-Derived Small Extracellular Vesicles from Patients with Alzheimer's Disease 42
null 5
null 1
Totale 6.273
Categoria #
all - tutte 24.494
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.494


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019268 0 0 0 0 0 0 0 0 0 0 152 116
2019/20202.419 64 124 278 799 84 174 128 134 112 315 146 61
2020/20211.556 148 100 184 184 165 141 257 91 77 49 128 32
2021/2022305 60 28 66 25 2 4 10 85 4 14 5 2
2022/2023731 84 2 6 98 65 170 0 104 134 10 49 9
2023/2024198 17 22 29 34 38 37 2 7 0 12 0 0
Totale 6.273